ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 656925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 656925; 2) Community: the network communities that were significantly associated with the response to NSC 656925; 3) Molecule: the relationships between components within communities and NSC 656925; 4) MDR: the compounds that were significantly associated with the NSC 656925.

NSC Compound Enrichment Correlation
NSC 643838 Null 0.0105244982742819 0.17181731
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0105244982742819 0.21409822
NSC 651605 Null 0.0105244982742819 0.43300697
NSC 681632 Camptothecin Derivative 0.0105244982742821 0.37108508
NSC 681633 Camptothecin Derivative 0.0105244982742821 0.28275266
NSC 683694 Null 0.0105244982742821 0.37945984
NSC 691562 [1]Benzothiepino[4,5-c]pyridine-1-carbonitrile, 2-amino-4-(3,4-dimethoxyphenyl)-5,6-dihydro-10-methyl- 0.0105244982742821 0.41540836
NSC 697504 Null 0.0105244982742821 0.27535481
NSC 700363 Liposomal Annamycin 0.0105244982742821 0.30272235
NSC 721154 11-Cyanomethylen-2-methoxy-6-methyl-11H-indolo[1,2-b]indazol ium trifluoromethanesulfonate 0.0105244982742821 0.22261763
Total:80  Current:15    [First] [Prev] [Next] [Last]